NO893879L - Fremgangsmaate for fremstilling av pteridinholdige legemidler. - Google Patents

Fremgangsmaate for fremstilling av pteridinholdige legemidler.

Info

Publication number
NO893879L
NO893879L NO89893879A NO893879A NO893879L NO 893879 L NO893879 L NO 893879L NO 89893879 A NO89893879 A NO 89893879A NO 893879 A NO893879 A NO 893879A NO 893879 L NO893879 L NO 893879L
Authority
NO
Norway
Prior art keywords
group
pteridines
preparation
substituted
carbon atom
Prior art date
Application number
NO89893879A
Other languages
English (en)
Other versions
NO893879D0 (no
NO175979B (no
NO175979C (no
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO893879D0 publication Critical patent/NO893879D0/no
Publication of NO893879L publication Critical patent/NO893879L/no
Publication of NO175979B publication Critical patent/NO175979B/no
Publication of NO175979C publication Critical patent/NO175979C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO893879A 1988-10-01 1989-09-29 Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner NO175979C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (4)

Publication Number Publication Date
NO893879D0 NO893879D0 (no) 1989-09-29
NO893879L true NO893879L (no) 1990-04-02
NO175979B NO175979B (no) 1994-10-03
NO175979C NO175979C (no) 1995-01-11

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893879A NO175979C (no) 1988-10-01 1989-09-29 Analogifremgangsmåte for fremstilling av terapeutisk aktive pteridiner

Country Status (19)

Country Link
EP (1) EP0362645B1 (no)
JP (1) JPH02256676A (no)
KR (1) KR910006289A (no)
AT (1) ATE106728T1 (no)
AU (1) AU620645B2 (no)
DD (1) DD299062A5 (no)
DE (2) DE3833393A1 (no)
DK (1) DK480489A (no)
ES (1) ES2056174T3 (no)
FI (1) FI92699C (no)
HU (1) HU205761B (no)
IL (1) IL91814A (no)
MX (1) MX9203034A (no)
NO (1) NO175979C (no)
NZ (1) NZ230833A (no)
PT (1) PT91836B (no)
SU (1) SU1720491A3 (no)
UA (1) UA8028A1 (no)
ZA (1) ZA897414B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533464A (ja) * 1998-12-28 2002-10-08 カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント プテリジン誘導体の免疫抑制作用
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
AU2004271721A1 (en) * 2003-09-12 2005-03-24 4 Aza Bioscience Nv Pteridine derivatives for the treatment of septic shock and TNF-alpha-related diseases.
AU2004283479A1 (en) * 2003-10-17 2005-05-06 4 Aza Bioscience Nv Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
CU20180011A7 (es) 2015-03-04 2018-06-05 Gilead Sciences Inc Composiciones farmacéuticas que comprenden compuestos derivados de diaminopirido (3,2-d) como moduladores de receptor de tipo toll
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
PL3507276T3 (pl) 2016-09-02 2022-02-21 Gilead Sciences, Inc. Związki modulatory receptorów toll-podobnych
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (no) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
MX9203034A (es) 1992-07-01
IL91814A (en) 1994-02-27
NO893879D0 (no) 1989-09-29
ES2056174T3 (es) 1994-10-01
ZA897414B (en) 1991-06-26
NZ230833A (en) 1991-05-28
UA8028A1 (uk) 1995-12-26
DK480489D0 (da) 1989-09-29
DK480489A (da) 1990-04-02
EP0362645A3 (de) 1992-03-25
DE3833393A1 (de) 1990-04-05
KR910006289A (ko) 1991-04-29
FI92699B (fi) 1994-09-15
EP0362645B1 (de) 1994-06-08
HU205761B (en) 1992-06-29
AU620645B2 (en) 1992-02-20
FI894615A0 (fi) 1989-09-29
DE58907824D1 (de) 1994-07-14
HUT52504A (en) 1990-07-28
EP0362645A2 (de) 1990-04-11
AU4174989A (en) 1990-04-05
DD299062A5 (de) 1992-03-26
IL91814A0 (en) 1990-06-10
PT91836A (pt) 1990-04-30
NO175979B (no) 1994-10-03
FI894615A (fi) 1990-04-02
ATE106728T1 (de) 1994-06-15
JPH02256676A (ja) 1990-10-17
NO175979C (no) 1995-01-11
FI92699C (fi) 1994-12-27
PT91836B (pt) 1995-07-18
SU1720491A3 (ru) 1992-03-15

Similar Documents

Publication Publication Date Title
NO893879L (no) Fremgangsmaate for fremstilling av pteridinholdige legemidler.
ES443725A1 (es) Metodo para producir un producto hipotensor.
ATE156823T1 (de) Therapeutische heterocyclische verbindungen
HUT41713A (en) Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof
ES390924A1 (es) Procedimiento para la preparacion de derivados del acido nicotinico.
ES8308559A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ES390064A1 (es) Procedimiento de preparacion de derivados de aminometil-4'-espiro (dibenzo (a-d) cicloheptadi-z(o tri) eno-5:2'-dioxo- lano (1',3')).
EP0233291A4 (en) 2-ARYLBENZOTHIAZINE DERIVATIVES.
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
ES345994A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
ES345991A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES8200347A1 (es) Procedimiento de preparacion de derivados de la piridina.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
HUT64940A (en) Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
FR2670492B1 (fr) Nouveaux derives d'aminoalkylcetone, leur procede de preparation et leurs applications en therapeutique.
ATE28644T1 (de) Gamma-butyrolactonderivate mit herzmuskelschonender und antiarrhythmischer wirkung, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
GB1102765A (en) Ergolenyl-carboxylic acid amides